| Current Price | $2.27 | Mkt Cap | $26.2M |
|---|---|---|---|
| Open | $2.39 | P/E Ratio | -0.77 |
| Prev. Close | $2.27 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.25 - $2.48 | Volume | 46,403 |
| 52-Wk Range | $2.08 - $9.75 | Avg. Daily Vol. | 65,234 |
A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics.
| Current Price | $2.27 | Mkt Cap | $26.2M |
|---|---|---|---|
| Open | $2.39 | P/E Ratio | -0.77 |
| Prev. Close | $2.27 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.25 - $2.48 | Volume | 46,403 |
| 52-Wk Range | $2.08 - $9.75 | Avg. Daily Vol. | 65,234 |
The best Bull and Bear pitches based on recency and number of recommendations.
An injectable ED Drug? Yeah I don't think that's going to work.http://www.thestreet.com/story/11171001/2/biotech-stock-mailbag-ranking-cheap-biotechs.html
Read the most recent pitches from players about PTN.
Recs
LPTIM
(< 20)
Submitted: 2/14/2021 8:06:16 PM :
Start Price:
$4.61
NYSE MKT:PTN Score:
-56.23
MOVING UP FOR SURE
TAKE A LOOK
Recs
sk2129
(32.51)
Submitted: 9/17/2015 11:04:53 AM :
Start Price:
$28.00
NYSE MKT:PTN Score:
-191.02
baker bros
Recs
vzuopsref
(< 20)
Submitted: 8/16/2015 8:52:10 AM :
Start Price:
$27.00
NYSE MKT:PTN Score:
-193.70
Pending FDA approval of competitor's similar drug
Find the members with the highest scoring picks in PTN.
007191 (< 20) Score: +322.99
The Score Leader is the player with the highest score across all their picks in PTN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| 007191 | < 20 | 10/18/2006 |
|
1Y | $68.50 | -96.69% | +226.30% | +322.99 | 0 Comment | |
| Perse1 | < 20 | 2/12/2007 |
|
1Y | $56.25 | -95.96% | +211.05% | +307.01 | 0 Comment | |
| jbwest | 86.01 |
|
|
1Y | $47.00 | -95.17% | +210.82% | +305.99 | 0 Comment | |
| allstar31 | 99.95 | 9/15/2014 |
|
5Y | $23.75 | -90.44% | +111.80% | +202.24 | 1 Comment | |
| bbbensphone | 68.88 | 2/29/2016 |
|
5Y | $12.50 | -81.84% | +116.20% | +198.04 | 0 Comment | |
| Almostperfect1 | 71.65 | 12/23/2022 |
|
5Y | $2.36 | -3.81% | +11.07% | -14.89 | 0 Comment | |
| justaboutperfect | 31.03 | 2/16/2023 |
|
5Y | $2.78 | -18.35% | +3.05% | -21.39 | 0 Comment | |
| mn1 | < 20 | 8/31/2022 |
|
5Y | $4.61 | -50.76% | +5.47% | -56.23 | 0 Comment | |
| kfassini | < 20 | 8/31/2022 |
|
5Y | $4.61 | -50.76% | +5.47% | -56.23 | 0 Comment | |
| LPTIM | < 20 | 8/31/2022 |
|
3M | $4.61 | -50.76% | +5.47% | -56.23 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
